Phase I Study of Weekly Cisplatin, Bolus Fluorouracil and Escalating Doses of Irinotecan in Advanced Solid Tumors

By Ku Geoffrey   O'Reilly Eileen   Saltz Leonard   Schrag Deborah   Maki Robert   Kelsen David   Ilson David  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 402-406

Informa Healthcare

Access to resources Recommend Favorite

A Phase I-II Trial of Fixed-dose Carboplatin and Escalating Paclitaxel in Advanced Ovarian Cancer

By Bolis G.   Scarfone G.   Zanaboni F.   Villa A.   Presti M.   Melpignano M.   Ferraris C.   Tateo S.   Guarnerio P.   Gentile A.   Parazzini F.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 592-595

Elsevier

Access to resources Recommend Favorite

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

By Kim Jong   Sohn Sang   Song Hong   Kwon Ki-Young   Do Young   Lee Kyung   Hyun Myung   Ryoo Hun   Bae Sung   Park Keon   Baek Jin   Lee Won   Chung Joo   Cho Goon   Sohn Chang-Hak   Jang Jung   Chung Ho   Yu Wansik  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study

By Stathopoulos George   Rigatos Sotiris   Christodoulou Christos   Malamos Nikos   Deliyiannis Filippos   Stathopoulos John   Skarlos Dimosthenis  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 3, 2004-09 ,pp. : 259-264

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer

By Hara Takuo   Omura Kenji   Hirano Makoto   Asada Yasuyuki   Munemoto Yoshinori   Sakamoto Junichi  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 631-636

Springer Publishing Company

Access to resources Recommend Favorite